Quality assurance measures provide cost savings to payers.
“As healthcare providers and patients become more aware of the importance of personal and family history risk factors for hereditary cancer syndromes, the demand for genetic testing will continue to increase. As such, working with a diagnostic laboratory that provides extensive clinical QA measures whose goal is to support the most clinically appropriate care, while simultaneously avoiding unnecessary healthcare spending, is critical to the success of personalized medicine.”
Smith S, et al. Optimization of quality assurance to increase clinical utility and cost effectiveness of hereditary cancer testing. Per Med 2017; 14(3), 213-20.